Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CA102N
i
Other names:
CA102N, CA-102N, CA 102, hyaluronic acid nimesulide-NH2 bioconjugate, Nim-HA Conjugate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Holy Stone Healthcare
Drug class:
COX2 inhibitor, CD44-targeted small molecule-drug conjugate
Related drugs:
‹
celecoxib (3)
amlodipine/celecoxib (1)
parecoxib (1)
DRGT-46 (1)
apricoxib (0)
ECP-1014 (0)
celecoxib oral (0)
ETS2101 (0)
VT-11CR (0)
celecoxib (3)
amlodipine/celecoxib (1)
parecoxib (1)
DRGT-46 (1)
apricoxib (0)
ECP-1014 (0)
celecoxib oral (0)
ETS2101 (0)
VT-11CR (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login